One of the most relevant brands among our more than 25 partners is TargetMol
We have reached an agreement with TargetMol: CymitQuimica clients will benefit for a 20% discount on all TargetMol products until the end of the year.On our website you can find the products offered by this partner, which has become one of the world's most recognised compound libraries and small molecule inhibitors supplier. TargetMol offers approximately 120 compound libraries and a wide range of chemical products and kits for life sciences.
Ends on Dec 31( 7 days left )
CTX-0294885 hydrochloride
CTX-0294885 hydrochloride inhibits 235 kinases, affects AKT family, and aids in studying kinome-related diseases.Formula:C22H25Cl2N7OColor and Shape:SolidMolecular weight:474.39Lesogaberan hydrochloride
Lesogaberan (AZD-3355) HCl: selective GABA B agonist, EC50 8.6 nM, K i 5.1 nM (rat GABA B), 1.4 μM (GABA A), reduces esophageal relaxation.Formula:C3H10ClFNO2PColor and Shape:SolidMolecular weight:177.54DPM-1001 trihydrochloride
DPM-1001 trihydrochloride: Potent PTP1B inhibitor, IC50 100 nM, oral, non-competitive, anti-diabetic.Formula:C35H60Cl3N3O3Color and Shape:SolidMolecular weight:677.23Altretamine hydrochloride
CAS:Altretamine hydrochloride is an alkylating antineoplastic agent.Formula:C9H19ClN6Color and Shape:SolidMolecular weight:246.74ATM-3507 trihydrochloride
CAS:ATM-3507 trihydrochloride, a potent inhibitor of tropomyosin, demonstrates inhibition concentration (IC50) values ranging from 3.83 to 6.84 μM across variousFormula:C37H49Cl3FN5O2Color and Shape:SolidMolecular weight:721.17GS-441524
CAS:GS-441524 treatment of cats with naturally occurring feline infectious peritonitis.Formula:C12H13N5O4Purity:98.78% - 99.75%Color and Shape:SolidMolecular weight:291.26DSP-1053 benzenesulfonate
CAS:DSP-1053: Benzylpiperidine-based, potent SERT inhibitor (Ki=1.02nM), partial 5-HT1A receptor agonist (Ki=5.05nM), antidepressant.Formula:C32H38BrNO7SColor and Shape:SolidMolecular weight:660.62PF-06815345 hydrochloride
CAS:PF-06815345 HCl is an oral, potent PCSK9 inhibitor, IC50 13.4 μM, lowers PCSK9 in mice.Formula:C27H30Cl2FN9O4Color and Shape:SolidMolecular weight:634.49Anti-inflammatory agent 7
<p>Anti-inflammatory Agent 7 suppresses proinflammatory cytokines by hindering the NF-κB/MAPK signaling pathway in both LPS-treated RAW 264.7 cells and mice.</p>Formula:C36H40N4O9Color and Shape:SolidMolecular weight:672.72NK1 receptor antagonist 2
CAS:NK1 Receptor Antagonist 2, a compound targeting the NK1 receptor, holds potential for tinnitus and hearing loss research.Formula:C31H35F7N4O2Color and Shape:SolidMolecular weight:628.62β2AR/M-receptor agonist-2
CAS:<p>β2AR/M-receptor agonist-2 is a dual-function compound acting as a muscarinic antagonist and β2 adrenoceptor agonist (MABA).</p>Formula:C36H49ClN4O7SColor and Shape:SolidMolecular weight:717.31PF-4348235 HCl
<p>PF-4348235 HCl (β2AR/M-receptor agonist-2 HCl) is a muscarinic M3 receptor antagonist (Ki: 0.73 nM) and β2 adrenergic receptor agonist (MABA, EC50: 3.7 nM). PF-4348235 HCl is also a bronchial BM213 acetate is a bronchodilator used to study cardiovascular and respiratory diseases such as chronic obstructive pulmonary disease (COPD).</p>Formula:C36H50Cl2N4O7SPurity:98.81%Color and Shape:SolidMolecular weight:753.78PF-4348235 2HCl
<p>PF-4348235 2HCl is an adrenergic agonist and muscarinic receptor antagonist, and is a bronchodilator.</p>Formula:C36H51Cl3N4O7SPurity:99.85%Color and Shape:SolidMolecular weight:790.24PI3K/Akt/CREB activator 1
CAS:<p>PI3K/Akt/CREB activator 1 (AE-18) is an iNOS inhibitor that can be used to study vascular dementia and Parkinson's.</p>Formula:C19H15F4NO3Color and Shape:SolidMolecular weight:381.32Antitrypanosomal agent 10
Antitrypanosomal agent 10, an antitrypanosomal compound, effectively inhibits Trypanosoma cruzi with an IC50 of 0.28 μM.Formula:C17H9F6N5OColor and Shape:SolidMolecular weight:413.28Antitrypanosomal agent 11
Antitrypanosomal Agent 11 is a chemical compound effective against Trypanosoma cruzi, exhibiting an inhibition concentration (IC 50) of 0.23 μM.Formula:C16H10F6N6OColor and Shape:SolidMolecular weight:416.28Gestrinone
CAS:Gestrinone (R 2323) 是一种合成类固醇激素，能够抑制平滑肌瘤(IC50:43.67 μM)，有用于子宫内膜异位症的研究潜力。Formula:C21H24O2Purity:99.21%Color and Shape:Light Yellow SolidMolecular weight:308.41SARS-CoV-2/MERS Mpro-IN-1
SARS-CoV-2/MERS Mpro-IN-1 is a potent inhibitor of the main proteases in SARS-CoV-2 and MERS, exhibiting IC50 values of 0.10 and 0.06 µM, respectively.Formula:C30H36N4O7Color and Shape:SolidMolecular weight:564.63SARS-CoV-2/MERS Mpro-IN-2
<p>SARS-CoV-2/MERS Mpro-IN-2 is a potent inhibitor of the main proteases of SARS-CoV-2 and MERS, demonstrating IC50 values of 0.21 and 0.07 µM, respectively.</p>Formula:C28H30Cl2N4O6Color and Shape:SolidMolecular weight:589.473β-Hydroxy-hop-22(29)-ene
CAS:3β-Hydroxy-hop-22(29)-ene is a potent antiparasitic compound demonstrating moderate efficacy against Trypanosoma cruzi and Leishmania mexicana.Formula:C30H50OColor and Shape:SolidMolecular weight:426.72Antibacterial synergist 2
CAS:"Antibacterial Synergist 2 inhibits biofilms of S. enterica, S. aureus, P. aeruginosa, and C. albicans."Formula:C6H3Br3O2Color and Shape:SolidMolecular weight:346.8erythro-Austrobailignan-6
CAS:Erythro-Austrobailignan-6: orally active, anti-cancer, inhibits DNA topoisomerases, induces apoptosis, boosts p38/JNK phosphorylation.Formula:C20H24O4Color and Shape:SolidMolecular weight:328.4JBJ-09-063 hydrochloride
JBJ-09-063 hydrochloride: targeted EGFR inhibitor, effective for various mutations and TKI-resistant lung cancer models.Formula:C31H30ClFN4O3SColor and Shape:SolidMolecular weight:593.11DDO-2093 dihydrochloride
DDO-2093 dihydrochloride: potent MLL1-WDR5 inhibitor, IC50=8.6 nM, Kd=11.6 nM, antitumor.Formula:C29H39Cl3FN9O3Color and Shape:SolidMolecular weight:687.04Anabasine
CAS:Anabasine ((S)-Anabasine) is from tobacco. Anabasine is a full agonist of nicotinic acetylcholine receptors (nAChRs) with insecticidal activity.Formula:C10H14N2Purity:99.27%Color and Shape:Colorless Liquid Darkens On Exposure To Air White Fine Crystalline PowderMolecular weight:162.23Romifidine hydrochloride
CAS:Romifidine hydrochloride, an α2 adrenergic receptor agonist, induces sedation effects in vivo.Formula:C9H10BrClFN3Color and Shape:SolidMolecular weight:294.55Teslexivir hydrochloride
CAS:Teslexivir (BTA074) HCl inhibits HPV 6/11 by blocking E1-E2 protein interaction, vital for DNA replication. Used in condyloma research.Formula:C35H37BrClN3O4Color and Shape:SolidMolecular weight:679.04DYRKs-IN-1 hydrochloride
CAS:DYRKs-IN-1 HCl inhibits DYRK1A (5 nM IC50) & DYRK1B (8 nM IC50) with antitumor properties.Formula:C30H31Cl2N7O4Color and Shape:SolidMolecular weight:624.52Cyclic-di-GMP diammonium
CAS:C-di-GMP diammonium activates STING, regulates biofilms, motility, and virulence in bacteria.Formula:C20H30N12O14P2Color and Shape:SolidMolecular weight:724.47CBB1007 trihydrochloride
CBB1007 trihydrochloride inhibits hLSD1 selectively (IC50=5.27μM), blocks demethylation of H3K4Me2/Me, and activates certain genes.Formula:C27H37Cl3N8O4Color and Shape:SolidMolecular weight:643.99Fomepizole hydrochloride
CAS:Fomepizole hydrochloride inhibits CYP2E1 and alcohol dehydrogenase, blocking toxic metabolites, and treats methanol/ethylene glycol poisoning.Formula:C4H7ClN2Color and Shape:SolidMolecular weight:118.56Bicuculline methobromide
CAS:Bicuculline methobromide: GABAA antagonist, IC50=3μM, induces convulsions, used in epilepsy research.Formula:C21H20BrNO6Color and Shape:SolidMolecular weight:462.29Ladostigil hydrochloride
CAS:Ladostigil hydrochloride: oral dual cholinesterase and MAO-B/AChE inhibitor; IC50s: 37.1 & 31.8 μM; potential for depression and Alzheimer's research.Formula:C16H21ClN2O2Color and Shape:SolidMolecular weight:308.8MRS2768 tetrasodium salt
CAS:MRS2768 tetrasodium: a P2Y2 agonist; offers cardioprotection against ischemia.Formula:C15H16N2Na4O18P4Color and Shape:SolidMolecular weight:728.14BMS-823778 hydrochloride
CAS:<p>BMS-823778 hydrochloride is a potent, selective, and orally active inhibitor of 11β-HSD1 (11β-Hydroxysteroid Dehydrogenase Type 1), demonstrating an IC50 (half</p>Formula:C18H19Cl2N3OColor and Shape:SolidMolecular weight:364.27AnaMorelin hydrochloride
CAS:AnaMorelin hydrochloride (RC-1291 hydrochloride) is a novel ghrelin receptor agonist(EC50 : 0.74 nM, in the FLIPR assay).Formula:C31H43ClN6O3Purity:99.18% - ≥98%Color and Shape:SolidMolecular weight:583.164aα,7α,7aα-Nepetalactone
CAS:4aα,7α,7aα-Nepetalactone is a natural terpenoid lactone exhibiting antibacterial activity against E. coli, P. aeruginosa, S. aureus, and others.Formula:C10H14O2Purity:99.94%Color and Shape:SolidMolecular weight:166.22RORγt inverse agonist 14
CAS:RORγt inverse agonist 14 (8e) is a potent, selective, and orally active compound with an EC50 of 2.5 nM, exhibiting anti-inflammatory activity.Formula:C26H26F8N2O6S2Purity:98%Color and Shape:SolidMolecular weight:678.61AXC-715 trihydrochloride
CAS:AXC-715 trihydrochloride is a TLR7/8 agonist used to make PD-L1 adjuvanted antibody immunocouplings.Formula:C18H28Cl3N5Purity:99.87%Color and Shape:SolidMolecular weight:420.81RORγt inverse agonist 26
CAS:RORγt inverse agonist 26, a potent reverse agonist of RORγt, effectively modulates Th17 cell differentiation and suppresses IL-17 production.Formula:C27H21F7N2O5SColor and Shape:SolidMolecular weight:618.52BRM/BRG1 ATP Inhibitor-3
CAS:<p>BRM/BRG1 ATP Inhibitor-3 targets BRM/BRG1 (IC50: 10.4/19.3 nM) for cancer/BAF disorder research.</p>Formula:C26H25N5O2S2Color and Shape:SolidMolecular weight:503.64BRM/BRG1 ATP Inhibitor-4
CAS:<p>BRM/BRG1 ATP Inhibitor-4, a potent inhibitor of BRG1/BRM, is utilized in the research of cancers and BAF complex-related disorders.</p>Formula:C25H32N6O3SColor and Shape:SolidMolecular weight:496.623-Chlorogentisyl alcohol
CAS:3-Chlorogentisyl alcohol: E. coli β-glucuronidase inhibitor (IC50=0.74µM, Ki=0.58µM), antiproliferative, for anti-cancer/inflammatory research.Formula:C7H7ClO3Color and Shape:SolidMolecular weight:174.58Antileishmanial agent-13
CAS:Antileishmanial agent-13, a quinoline-isatin hybrid, targets L. Major with IC50s of 0.604 μM (promastigote) and 0.508 μM (amastigote).Formula:C17H10BrClN4OColor and Shape:SolidMolecular weight:401.64Metallo-β-lactamase-IN-9
CAS:Metallo-β-lactamase-IN-9 (Compound 23) serves as a broad-spectrum inhibitor of metallo-beta-lactamases (MBL), exhibiting inhibition constants (IC50) of 35 nMFormula:C13H12N6O3SColor and Shape:SolidMolecular weight:332.34Antituberculosis agent-6
CAS:<p>Antituberculosis agent-6: potent against M. tuberculosis (MIC 3.49 μM), antifungal (MIC 62.5 μM), high GI absorption.</p>Formula:C27H20F2N2O3Color and Shape:SolidMolecular weight:458.46Antituberculosis agent-8
CAS:Antituberculosis agent-8: MIC 3.53 μM vs M. tuberculosis, antifungal MIC 62.50 μM vs A. niger.Formula:C25H19F3N2O3Color and Shape:SolidMolecular weight:452.43Eltrombopag methyl ester
CAS:Eltrombopag methyl ester, a Tpo receptor agonist derivative, boosts platelet production for thrombocytopenia research.Formula:C26H24N4O4Color and Shape:SolidMolecular weight:456.49Antitrypanosomal agent 9
CAS:Agent 9 inhibits T. b. brucei (IC50: 1.15 μM), used in HAT research.Formula:C22H27NO3Color and Shape:SolidMolecular weight:353.45TAK-960 dihydrochloride
<p>TAK-960 dihydrochloride: oral PLK1 inhibitor, IC50 0.8 nM; also Hinders PLK2 and PLK3 (IC50s 16.9/50.2 nM); curbs cancer cell growth.</p>Formula:C27H36Cl2F3N7O3Color and Shape:SolidMolecular weight:634.52WYE-687 dihydrochloride
CAS:WYE-687 dihydrochloride is an mTOR inhibitor with IC50 of 7 nM, also targeting PI3Kα (81 nM) and PI3Kγ (3.11 μM).Formula:C28H34Cl2N8O3Color and Shape:SolidMolecular weight:601.53Glibenclamide potassium
CAS:<p>Glibenclamide potassium, a more soluble form of Glibenclamide, exists as anhydrous and hydrate salts.</p>Formula:C23H27ClKN3O5SColor and Shape:SolidMolecular weight:532.09IACS-9571 hydrochloride
CAS:IACS-9571 hydrochloride: potent TRIM24/BRPF1 inhibitor; IC50 = 8 nM (TRIM24); Kd = 31 nM (TRIM24), 14 nM (BRPF1).Formula:C32H43ClN4O8SColor and Shape:SolidMolecular weight:679.22EG01377 dihydrochloride
<p>EG01377 dihydrochloride inhibits NRP1 selectively with Kd 1.32 μM, IC50 609 nM, and has antiangiogenic and antitumor properties.</p>Formula:C26H32Cl2N6O6S2Color and Shape:SolidMolecular weight:659.6CM-579 trihydrochloride
CM-579 trihydrochloride: reversible G9a/DNMT inhibitor with IC50s 16 nM (G9a) & 32 nM (DNMT); potent against various cancer cells.Formula:C29H43Cl3N4O3Color and Shape:SolidMolecular weight:602.04Flurandrenolone Acetate
CAS:Flurandrenolone Acetate, a synthetic glucocorticoid derived from Flurandrenolide, is used to study skin issues like eczema and psoriasis.Formula:C26H35FO7Color and Shape:SolidMolecular weight:478.55PBT434 methanesulfonate
CAS:PBT434 methanesulfonate is an oral α-synuclein aggregation inhibitor, crosses the blood-brain barrier, and may help treat Parkinson's.Formula:C13H17Cl2N3O5SColor and Shape:SolidMolecular weight:398.26Caspase-9 Inhibitor III
CAS:Caspase-9 Inhibitor III (Ac-LEHD-cmk) blocks caspase-9, protects against ischemic heart damage.Formula:C24H35ClN6O9Color and Shape:SolidMolecular weight:587.02Ebaresdax hydrochloride
CAS:Ebaresdax hydrochloride has analgesic activity and is used in the study of painful diabetic neuropathy caused by type I or type II diabetes.Formula:C12H15ClN2O3SPurity:99.11% - 99.77%Color and Shape:SolidMolecular weight:302.78(+)-Dihydrocalanolide A
CAS:DHCal A (NSC 678323) is an oral nonnucleoside Reverse Transcriptase inhibitor for HIV research.Formula:C22H28O5Color and Shape:SolidMolecular weight:372.45Glucokinase activator 3
CAS:Glucokinase activator 3: potent GK activator, AC50=38 nM, potential for type 2 diabetes research.Formula:C26H33N2O9PS2Color and Shape:SolidMolecular weight:612.65LC kinetic stabilizer-1
CAS:LC kinetic stabilizer-1: potent, selective for amyloid light chains, EC50: 140 nM (WIL-FL*), 74.1 nM (WIL-FL*T46L/F49Y).Formula:C27H31N5O3Color and Shape:SolidMolecular weight:473.57LC kinetic stabilizer-2
CAS:LC Kinetic Stabilizer-2 is a powerful stabilizer for amyloidogenic immunoglobulin light chains (LC), demonstrating significant efficacy with an EC50 of 24 nM.Formula:C28H31N3O3Color and Shape:SolidMolecular weight:457.56Type II TRK inhibitor 1
CAS:Type II TRK Inhibitor 1 is a potent inhibitor targeting multiple tropomyosin receptor kinase (TRK) fusion protein variants as well as the wild type.Formula:C35H33F3N8O3Purity:98%Color and Shape:SolidMolecular weight:670.68Mitochondria degrader-1
CAS:Mitochondria degrader-1, a potent autophagy inducer, aids in neurodegenerative, cancer, and aging disease research.Formula:C33H49ClFN7O8SColor and Shape:SolidMolecular weight:758.3Tilpisertib fosmecarbil
CAS:Tilpisertib fosmecarbil is a potent inhibitor of serine/threonine kinases with anti-inflammatory properties.Formula:C35H36ClN8O7PColor and Shape:SolidMolecular weight:747.14S1P5 receptor agonist-1
CAS:S1P5 Receptor Agonist-1 (example 6) is a highly potent and selective agonist for the S1P5 receptor, exhibiting an EC50 value of 20 nM.Formula:C20H24F3NO3Color and Shape:SolidMolecular weight:383.4VU6036720 hydrochloride
VU6036720 hydrochloride inhibits Kir4.1/5.1. channels with 0.24 μM IC50; used in brain and kidney research.Formula:C20H23Cl2FN4O2SColor and Shape:SolidMolecular weight:473.39Cathepsin K inhibitor 3
CAS:Cathepsin K inhibitor 3: Selective, IC50 of 0.5 nM, good pharmacokinetics, potential for OA research.Formula:C30H31FN4O4SColor and Shape:SolidMolecular weight:562.65Mtb-cyt-bd oxidase-IN-1
<p>Mtb-cyt-bd oxidase-IN-1, a Mycobacterium tuberculosis inhibitor, IC50: 0.13 μM, useful for TB research.</p>Formula:C26H35NO2Color and Shape:SolidMolecular weight:393.56Mtb-cyt-bd oxidase-IN-3
Mtb-cyt-bd oxidase-IN-3 inhibits M. tuberculosis growth, IC50 0.36 μM, MIC 32 μM, for TB research.Formula:C26H35NO2Color and Shape:SolidMolecular weight:393.56Mtb-cyt-bd oxidase-IN-4
Mtb-cyt-bd oxidase inhibitor; IC50=0.25μM; MIC=8μM against Mycobacterium tuberculosis; for TB research.Formula:C25H32FNOColor and Shape:SolidMolecular weight:381.53Mtb-cyt-bd oxidase-IN-6
CAS:Mtb-cyt-bd oxidase-IN-6, a potent inhibitor of Mycobacterium tuberculosis (Mtb) cytochrome bd (cyt-bd) oxidase (MtbCyt-bd Oxidase), exhibits an inhibitoryFormula:C20H27NOColor and Shape:SolidMolecular weight:297.43Antibacterial agent 124
CAS:Antibacterial agent 124 inhibits Sa ProRS with an IC50 of 0.18 μM.Formula:C16H17ClFN3O2Color and Shape:SolidMolecular weight:337.78Antibacterial agent 126
Antibacterial agent 126 combats biofilm, disrupts membranes, and boosts ROS/RNS to prevent drug resistance.Formula:C21H24NO6PColor and Shape:SolidMolecular weight:417.39Mtb-cyt-bd oxidase-IN-7
Mtb-cyt-bd oxidase-IN-7 inhibits Cyt-bd with 4.17 μM affinity and has anti-tuberculosis properties.Formula:C18H14F3NO2Color and Shape:SolidMolecular weight:333.3Mycobacterial Zmp1-IN-1
Zmp1-IN-1: An inhibitor of mycobacterial Zmp1 with dose-dependent anti-tuberculosis effects.Formula:C26H27N3O7SColor and Shape:SolidMolecular weight:525.57Antibacterial agent 131
Antibacterial agent 131 is a compound with antibacterial properties.Formula:C24H17ClN4OSPurity:99.63%Color and Shape:SolidMolecular weight:444.94Antibacterial agent 132
CAS:<p>Antibacterial agent 132 showed antimicrobial activity against C.</p>Formula:C24H17ClN4OSPurity:98%Color and Shape:SolidMolecular weight:444.94SARS-CoV-2 3CLpro-IN-10
SARS-CoV-2 3CLpro-IN-10(5d) inhibits 3CL protease: 190 nM (SARS-CoV-2), 790 nM (SARS-CoV-1), 70 nM (MERS-CoV), and has broad-spectrum antiviral effects.Formula:C24H33FN3NaO8SColor and Shape:SolidMolecular weight:565.59SARS-CoV-2 3CLpro-IN-11
SARS-CoV-2 3CLpro-IN-11, potent inhibitor: IC50 of 140nM for 3CLpro; 240nM for SARS-CoV-1; 70nM for MERS-CoV; broad-spectrum antiviral.Formula:C25H36N3NaO9SColor and Shape:SolidMolecular weight:577.62α-Synuclein inhibitor 8
CAS:α-Synuclein inhibitor 8 effectively impedes α-Synuclein aggregation and disaggregation with an IC50 of 2.5 µM, demonstrating substantial reduction in neuronalFormula:C24H20N2O6Color and Shape:SolidMolecular weight:432.43Caspase-3/7 activator 2
Caspase-3/7 activator 2 triggers apoptosis with tumor selectivity and anti-proliferative properties.Formula:C32H34N2O7Color and Shape:SolidMolecular weight:558.62Caspase-3/7 activator 3
Caspase-3/7 activator 3 triggers apoptosis with tumor selectivity and anti-proliferative effects.Formula:C24H27NO5Color and Shape:SolidMolecular weight:409.47CEP-28122 mesylate salt
<p>CEP-28122 mesylate, a diaminopyrimidine, selectively inhibits ALK with IC50 of 1.9 nM and exhibits antitumor effects.</p>Formula:C29H39ClN6O6SColor and Shape:SolidMolecular weight:635.17Trandolaprilate hydrate
CAS:Trandolaprilate hydrate, a powerful ACE inhibitor and Trandolapril's main metabolite, is lipophilic with partial c-fos blocking.Formula:C22H32N2O6Color and Shape:SolidMolecular weight:420.5Lewis y tetrasaccharide
CAS:Lewis Y tetrasaccharide, a derivative of Lewis X, is an antigen linked to ovarian cancer metastasis and bad prognosis.Formula:C26H45NO19Color and Shape:SolidMolecular weight:675.63AZ13705339 hemihydrate
AZ13705339 hemihydrate: potent PAK1 inhibitor (IC50: 0.33 nM), also binds PAK1/2 (Kd: 0.28/0.32 nM), for cancer research.Formula:C33H36FN7O3SH2OColor and Shape:SolidMolecular weight:638.77R 59-022 hydrochloride
CAS:<p>R 59-022 hydrochloride is a 5-HT antagonist, PKC activator, DGK inhibitor (IC50: 2.8 µM), and modulates lipid production in platelets and neutrophils.</p>Formula:C27H27ClFN3OSPurity:97.7%Color and Shape:SolidMolecular weight:496.04Antiarrhythmic agent-1
CAS:Antiarrhythmic agent-1 (example I), functioning as an antiarrhythmic agent and an IKr potassium channel blocker (IC 50 <1 μM), effectively inhibits cardiacFormula:C25H27N3O4SColor and Shape:SolidMolecular weight:465.56Lagociclovir valactate
CAS:Lagociclovir valactate is a prodrug of Lagociclovir . Lagociclovir valactate is an orally active anti- HBV agent [1] .Formula:C18H25FN6O6Color and Shape:SolidMolecular weight:440.43(-)-15-Deoxyspergualin
CAS:(-)-15-Deoxyspergualin is a potent antitumor agent that demonstrates significant inhibition against mouse leukemia L-1210.Formula:C17H37N7O3Color and Shape:SolidMolecular weight:387.52Cyclopropenone probe 1
<p>Cyclopropenone probe 1 targets and covalently modifies triple-negative breast cancer enzyme GSTP1 at its active site.</p>Formula:C12H8O2Color and Shape:SolidMolecular weight:184.19Antibacterial agent 19
CAS:Antibacterial agent 19 targets K. pneumoniae and multi-resistant S. aureus with MICs: 0.022 and 0.045 mg/mL.Formula:C16H16F2N2O4Color and Shape:SolidMolecular weight:338.31Antibacterial agent 64
CAS:Potent antibacterial, YycG inhibitor with 6.1 µM IC50. Synergistic with ampicillin against biofilm bacteria.Formula:C29H20ClN3O6S2Color and Shape:SolidMolecular weight:606.07KRAS G12C inhibitor 28
CAS:KRAS G12C Inhibitor 28 is a compound that effectively inhibits the KRAS G12C mutation, exhibiting potent antitumor effects with an inhibitory concentration (Formula:C33H36F2N5O4PColor and Shape:SolidMolecular weight:635.64KRAS G12C inhibitor 32
CAS:KRAS G12C Inhibitor 32, an eight-membered heterocyclic compound with nitrogen, acts as a potent inhibitor of KRAS G12C [1].Formula:C29H30Cl3FN6O3Purity:98%Color and Shape:SolidMolecular weight:635.94KRAS G12C inhibitor 45
CAS:KRAS G12C inhibitor 45 is a potent KRAS G12C inhibitor .Formula:C32H33F2N5O5SColor and Shape:SolidMolecular weight:637.7Plasma kallikrein-IN-2
Plasma kallikrein-IN-2: PKal inhibitor, IC50=0.1 nM. Used in angioedema, diabetic eye disease research.Formula:C28H24ClF3N8O3Color and Shape:SolidMolecular weight:612.99KRAS G12C inhibitor 35
CAS:<p>KRAS G12C inhibitor 35 targets KRAS G12C in cancer research (CN112920183A, compound 3).</p>Formula:C31H27ClF2N6O3Color and Shape:SolidMolecular weight:605.03
